The recent challenges in global chains have highlighted the value of securing critical medications like Ivermectin. Trusting on overseas vendors exposes countries to considerable vulnerabilities, including delivery delays, expense fluctuations, and even geopolitical concerns. Transitioning towards domestic procurement of Ivermectin offers a multitu